|
FAM96A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.358160E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.956100E-03 |
| Normal-vs-Stage2 |
5.758800E-01 |
| Normal-vs-Stage3 |
3.415600E-01 |
| Normal-vs-Stage4 |
4.448400E-01 |
| Stage1-vs-Stage2 |
1.631170E-01 |
| Stage1-vs-Stage3 |
7.132200E-02 |
| Stage1-vs-Stage4 |
1.684020E-01 |
| Stage2-vs-Stage3 |
9.164800E-01 |
| Stage2-vs-Stage4 |
9.411600E-01 |
| Stage3-vs-Stage4 |
9.831600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.318000E-02 |
| Normal-vs-AfricanAmerican |
8.601900E-03 |
| Normal-vs-Asian |
3.007600E-01 |
| Caucasian-vs-AfricanAmerican |
2.778600E-01 |
| Caucasian-vs-Asian |
8.323800E-01 |
| AfricanAmerican-vs-Asian |
2.583000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.048000E-02 |
| Normal-vs-Female |
2.667800E-02 |
| Male-vs-Female |
6.029600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.477190E-03 |
| Normal-vs-Age(41-60Yrs) |
1.030840E-01 |
| Normal-vs-Age(61-80Yrs) |
3.349600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.263800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.484300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.269700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.039000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.367400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.434800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.330400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.156400E-01 |
| Classical-VS-Follicular |
7.098000E-01 |
| Classical-VS-Other |
8.390000E-01 |
| Classical-VS-Normal |
1.238270E-02 |
| Tall-VS-Follicular |
5.030800E-01 |
| Tall-VS-Other |
6.610200E-01 |
| Tall-VS-Normal |
4.784200E-01 |
| Follicular-VS-Other |
9.749000E-01 |
| Follicular-VS-Normal |
5.578200E-02 |
| Other-VS-Normal |
5.008600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.876000E-01 |
| Normal-vs-N1 |
2.810600E-01 |
| N0-vs-N1 |
7.114600E-01 |
|
|
